Ontology highlight
ABSTRACT: Objective
This study describes the characteristics of children requiring admission with an acute lower-respiratory disease (ALRD) during the SARS-CoV-2 pandemics.Methods
Epidemiological, clinical, and microbiological data from patients with ALRD (pneumonia, bronchiolitis, bronchospasm) admitted to a reference paediatric hospital in Spain during the pandemic peak (week 11-20/2020) were prospectively analysed.Results
110 patients were included. 7 were SARS-CoV-2(+) and they were older in comparison to SARS-CoV-2(-). Among SARS-CoV-2(+) patients, pneumonia was the main clinical diagnosis (6/7) and bronchospasm was absent. Only 1 of 29 infants diagnosed with bronchiolitis was SARS-CoV-2(+). Lower values of leucocytes, lymphocytes, neutrophils, and platelets and higher values of creatinine were found in SARS-CoV-2(+). Human-rhinovirus/enterovirus was the main detection (11/32). There were not differences in PICU admission rates between SARS-CoV-2(+) and (-).Conclusions
Most of the ALRD episodes identified during the pandemics were not related to SARS-CoV-2 infection. SARS-CoV-2 was mainly found causing pneumonia in older children.
SUBMITTER: Mele M
PROVIDER: S-EPMC7577222 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature
Melé Maria M Henares Desiree D Pino Rosa R Asenjo Silvia S Matamoros Rocío R Fumadó Victoria V Fortuny Claudia C García-García Juan-José JJ Jordan Iolanda I Brotons Pedro P Muñoz-Almagro Carmen C de-Sevilla Mariona-Fernández MF Launes Cristian C
The Journal of infection 20201021 3
<h4>Objective</h4>This study describes the characteristics of children requiring admission with an acute lower-respiratory disease (ALRD) during the SARS-CoV-2 pandemics.<h4>Methods</h4>Epidemiological, clinical, and microbiological data from patients with ALRD (pneumonia, bronchiolitis, bronchospasm) admitted to a reference paediatric hospital in Spain during the pandemic peak (week 11-20/2020) were prospectively analysed.<h4>Results</h4>110 patients were included. 7 were SARS-CoV-2(+) and they ...[more]